[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard  Lowenthal M.B.A., M.S., MSMSEL", "age": 58, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 2746096, "exercisedValue": 0, "unexercisedValue": 2051778}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 2470993, "exercisedValue": 0, "unexercisedValue": 718122}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 57, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 55, "title": "Chief Operations Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 72, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Karas", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 618614, "exercisedValue": 0, "unexercisedValue": 4320554}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 34, "title": "Chief Business Officer & Secretary", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.4, "open": 13.08, "dayLow": 12.4753, "dayHigh": 13.665, "regularMarketPreviousClose": 13.4, "regularMarketOpen": 13.08, "regularMarketDayLow": 12.4753, "regularMarketDayHigh": 13.665, "payoutRatio": 0.0, "beta": 0.979, "trailingPE": 160.0, "forwardPE": -16.842106, "volume": 2797708, "regularMarketVolume": 2797708, "averageVolume": 1603922, "averageVolume10days": 2127890, "averageDailyVolume10Day": 2127890, "bid": 12.73, "ask": 12.83, "bidSize": 3, "askSize": 10, "marketCap": 1255933440, "fiftyTwoWeekLow": 7.55, "fiftyTwoWeekHigh": 18.51, "priceToSalesTrailing12Months": 14.088026, "fiftyDayAverage": 12.1278, "twoHundredDayAverage": 12.478775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1011336512, "profitMargins": 0.08971, "floatShares": 47452700, "sharesOutstanding": 98119800, "sharesShort": 19429266, "sharesShortPriorMonth": 16483868, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1984, "heldPercentInsiders": 0.22973, "heldPercentInstitutions": 0.7491, "shortRatio": 15.06, "shortPercentOfFloat": 0.3704, "impliedSharesOutstanding": 98119800, "bookValue": 2.622, "priceToBook": 4.8817697, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 7998000, "trailingEps": 0.08, "forwardEps": -0.76, "enterpriseToRevenue": 11.344, "enterpriseToEbitda": -336.663, "52WeekChange": 0.28902316, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 12.8, "targetHighPrice": 40.0, "targetLowPrice": 19.0, "targetMeanPrice": 29.5, "targetMedianPrice": 30.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 314022016, "totalCashPerShare": 3.2, "ebitda": -3004000, "totalDebt": 69425000, "quickRatio": 13.788, "currentRatio": 14.262, "totalRevenue": 89149000, "debtToEquity": 27.035, "revenuePerShare": 0.92, "returnOnAssets": -0.0066000004, "returnOnEquity": 0.03281, "grossProfits": 68592000, "freeCashflow": 8960125, "operatingCashflow": 13548000, "grossMargins": 0.76941, "ebitdaMargins": -0.0337, "operatingMargins": 0.54512, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1743811013, "regularMarketTime": 1743796801, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "regularMarketChangePercent": -4.4776077, "regularMarketPrice": 12.8, "earningsTimestamp": 1736767801, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1742473800, "earningsCallTimestampEnd": 1742473800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.08, "epsForward": -0.76, "epsCurrentYear": -1.4325, "priceEpsCurrentYear": -8.935428, "fiftyDayAverageChange": 0.6722002, "fiftyDayAverageChangePercent": 0.055426393, "twoHundredDayAverageChange": 0.32122517, "twoHundredDayAverageChangePercent": 0.025741722, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2025-04-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": -1.5625, "postMarketPrice": 12.6, "postMarketChange": -0.2, "regularMarketChange": -0.5999994, "regularMarketDayRange": "12.4753 - 13.665", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1603922, "fiftyTwoWeekLowChange": 5.25, "fiftyTwoWeekLowChangePercent": 0.69536424, "fiftyTwoWeekRange": "7.55 - 18.51", "fiftyTwoWeekHighChange": -5.71, "fiftyTwoWeekHighChangePercent": -0.3084819, "fiftyTwoWeekChangePercent": 28.902317, "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]